Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy

David G. Warnock*, Christie P. Thomas, Bojan Vujkovac, Ruth C. Campbell, Joel Charrow, Dawn A. Laney, Leslie L. Jackson, William R. Wilcox, Christoph Wanner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences